NEWTON, Mass. — Abcuro, Inc. has raised $66 million in a Series D financing to support a potentially registrational clinical study of ulviprubart in...
CAMBRIDGE, Mass. — Amylyx Pharmaceuticals, Inc. said its Phase 3 LUCIDITY trial of avexitide met its primary endpoint and all secondary endpoints in patients...
BOSTON — Ora has appointed João “John” Trein Jr., M.D., MPH, as Therapeutic Lead, Posterior, strengthening the ophthalmic contract research organization’s leadership in retinal...
CAMBRIDGE, Mass. — Researchers at the Whitehead Institute have discovered that small molecules called polyamines help protect cells from toxic iron buildup, a finding...
Waltham, Mass. — Thermo Fisher Scientific has completed proteomic analysis of about 5,500 research samples from The Michael J. Fox Foundation’s Parkinson’s Precision Medicine...
Denver, Colorado — TriSalus Life Sciences, Inc. reported second-quarter 2026 revenue of $11.4 million and maintained its full-year revenue guidance of $54 million to...
Recent Comments